GILEAD SCIENCES, INC. 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
GS GILEAD SCIENCES, INC. | Institutional Filer | ▼ 22.15% | $2.12B | 6 |
Current Portfolio Holdings
Showing top 6 reported positions by value (Total positions in database: 5)
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | ACLX | Arcellx, Inc. | Healthcare | 6.7M | $771.7M | 46.80% |
| 2 | RCUS | Arcus Biosciences, Inc. | Healthcare | 31.4M | $678.8M | 41.17% |
| 3 | GLPG | Galapagos N.V. | Healthcare | 16.7M | $501.2M | 30.40% |
| 4 | ASMB | Assembly Biosciences, Inc. | Healthcare | 4.5M | $125.0M | 7.58% |
| 5 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | 4.1M | $35.6M | 2.16% |
| 6 | XLO | Xilio Therapeutics, Inc. | Healthcare | 650K | $5.5M | 0.33% |
Showing 1 to 6 of 6 holdings